In conclusion, we have found for the first time that the semaphorins sema3A, sema3D, sema3E and sema3G possess anti-tumorigenic and anti-angiogenic properties similar to those displayed by the previously identified tumor suppressor sema3F. The gene discussed is SEMA3G; the disease is neoplasm.